Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

2 terminated/withdrawn out of 14 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
9(100.0%)
9Total
N/A(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07045766Not ApplicableWithdrawn

FaibaLite - Reduce Weight, One Bite at a Time

Role: collaborator

NCT07004504Completed

MEnstrual Cycle pHase ANd dIabeteS Management

Role: lead

NCT05540678Not ApplicableTerminated

The FibreGum Study - Changing the Course of Obesity in Children

Role: collaborator

NCT07087340Not ApplicableRecruiting

Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Role: collaborator

NCT07147010Not ApplicableCompleted

Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes

Role: lead

NCT05984979Recruiting

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes

Role: collaborator

NCT06282055Recruiting

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes

Role: lead

NCT07036692Not ApplicableRecruiting

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention

Role: collaborator

NCT05609175Completed

Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep

Role: collaborator

NCT06621030Not ApplicableNot Yet Recruiting

Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes

Role: collaborator

NCT06097689Not ApplicableCompleted

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus

Role: collaborator

NCT05933616Not ApplicableCompleted

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser

Role: collaborator

NCT05771090Not ApplicableCompleted

First Clinical Evaluation of a Novel Glucose Non-invasive Sensor Technology in Patients With Type 1 Diabetes

Role: lead

NCT05096325Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Role: collaborator

All 14 trials loaded